Study on interindividual variability in daptomycin pharmacokinetics and pharmacodynamics in patients with MRSA
Not Applicable
Recruiting
- Conditions
- infectious disease
- Registration Number
- JPRN-UMIN000035236
- Lead Sponsor
- Department of Hospital pharmacy, Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients discontinued the treatment of daptomycin 2. Patients assessed as inappropriate for the study enrollment by the attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The plasma concentrations of total and free daptomycin at 72 hours or later after initiation of daptomycin therapy
- Secondary Outcome Measures
Name Time Method